Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,690 across all filing types
Latest filing 2019-03-01 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, prices, compliance with regulations, and timing of repurchases. It does not contain financial statements or earnings data, nor is it a full report or presentation. The document is specifically about the company's buyback of its own shares, which fits the definition of a Transaction in Own Shares (POS) filing.
2019-03-01 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2018 年度业绩快报' which translates to '2018 Annual Performance Express Report' or '2018 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2018, including revenue, profit, net income, earnings per share, and other financial metrics. The document explicitly states that the data is preliminary, unaudited, and subject to change in the final annual report. It also mentions that the detailed audited financial data will be disclosed in the 2018 Annual Report. The document length is 2170 characters, which is relatively short and consistent with a brief earnings release rather than a full annual report. The content focuses on key financial highlights and performance metrics without detailed financial statements or comprehensive analysis. Therefore, this document is an Earnings Release (ER), which is the initial announcement of quarterly or annual financial results with key highlights only, not the full annual report (10-K) or audit report (AR). FY 2018
2019-02-27 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase program. It details the number of shares repurchased, the price range, total amount spent, and compliance with relevant regulations. It does not contain full financial statements or detailed financial analysis but is an update on capital activity related to share buybacks. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused on repurchase progress, not a full report or announcement of a report publication.
2019-02-11 Chinese
2018年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2018 annual performance forecast (业绩预告) from a company, indicating expected net profit growth for the full year 2018. It explicitly states that the forecast has not been audited and that detailed financial data will be disclosed in the 2018 annual report. The document is short (883 characters) and serves as a preliminary earnings outlook rather than a full financial report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only, not the full annual report itself. FY 2018
2019-01-28 Chinese
独立董事关于第三届董事会第十六次临时会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the appointment of a senior management member at Dirui Medical Technology Co., Ltd. It references compliance with company law, stock exchange listing rules, and company articles, and concludes with the agreement to appoint a vice general manager. The document is short (730 characters) and focuses on management appointment rather than financial data or report publication. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2019-01-15 Chinese
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from a company about the appointment of a senior management personnel, specifically the hiring of a new vice general manager. It includes details about the individual's background and confirms compliance with regulatory requirements. There is no financial data, no mention of financial results, no voting results, no legal proceedings, and no report publication. The content clearly fits the category of announcements related to changes in senior management or the board. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length and content support a high confidence in this classification.
2019-01-15 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.